Binswanger Named Exclusive Agent for Motorola Mobility's 1,136,311 Sq. Ft. Regional Headquarters Facility in Libertyville, Illinois
04 janv. 2013 10h25 HE | Binswanger
CHICAGO, IL--(Marketwire - Jan 4, 2013) - Binswanger has been named exclusive agent by Motorola Mobility Holdings, Inc. for the sale of its modern 1,136,311 sq. ft. headquarters facility on...
BRG Director Anne Marie Knott Awarded National Science Foundation Grant for Work on R&D Effectiveness
18 déc. 2012 10h30 HE | Berkeley Research Group, LLC
EMERYVILLE, CA--(Marketwire - Dec 18, 2012) - The National Science Foundation (NSF) has awarded Berkeley Research Group Director Anne Marie Knott a grant for her work examining the relationship...
Battelle-R&D Magazine Release Newest Global Research Funding Forecast
18 déc. 2012 09h39 HE | Battelle
COLUMBUS, OH--(Marketwire - Dec 18, 2012) - Global research and development (R&D) spending is forecast to grow by 3.7 percent -- or $53.7 billion -- in 2013 to $1.5 trillion, according to the...
Altuglas Logo
Plexiglas(R) Rnew Biopolymer Alloys Win R &D Magazine's 2012 Top 100 Award
12 nov. 2012 14h38 HE | Altuglas International
KING OF PRUSSIA, Pa., Nov. 12, 2012 (GLOBE NEWSWIRE) -- The R &D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics,...
TuftsCSDD-Logo-Color.jpg
Extraneous Data Collected in Clinical Trials Cost Drug Developers $4 Billion to $6 Billion Annually, According to Tufts Center for the Study of Drug Development
06 nov. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Nov 6, 2012) - One out of every five procedures performed during later stage clinical trials collects extraneous data and costs drug developers more than $1 million per...
TuftsCSDD-Logo-Color.jpg
Contract Support and Technical Service Providers Expected to Play a Growing Role in Drug Development, According to Tufts Center for the Study of Drug Development
17 oct. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Oct 17, 2012) - Drug sponsors and their contract service providers are using more sophisticated, integrated, and coordinated relationship structures to deliver greater...
TuftsCSDD-Logo-Color.jpg
Oncology Drugs Get Faster Approvals Than Non-Oncology Drugs in U.S., but the Opposite Is True in the EU, According to Tufts Center for the Study of Drug Development
05 sept. 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Sep 5, 2012) - Approval times for new oncology drugs in the United States during the last decade were shorter than approval times for non-oncology products, while the...
jetro_logo_with_name
A New Japanese Subsidy Program for Projects Promoting Asian Site Location in Japan
31 août 2012 17h48 HE | JETRO USA - Japan External Trade Organization
SAN FRANCISCO, Aug. 31, 2012 (GLOBE NEWSWIRE) -- The Japan External Trade Organization (JETRO) is pleased to announce a new Japanese subsidy program targeting projects that promote a new Regional...
TuftsCSDD-Logo-Color.jpg
Drug Companies Are Teaming With Academic Medical Centers to Create New Medicines, According to Tufts Center for the Study of Drug Development
07 août 2012 09h00 HE | Tufts Center for the Study of Drug Development
BOSTON, MA--(Marketwire - Aug 7, 2012) - Drug developers are forging new ways to work with academic medical centers to create the next generation of breakthrough medicines, which is changing the...
RTI.jpg
RTI Offers Free Licensing for Its RTI Connext Messaging Solution
18 juil. 2012 09h02 HE | Real-Time Innovations (RTI)
SUNNYVALE, CA--(Marketwire - Jul 18, 2012) - Real-Time Innovations (RTI), the world leader in delivering fast, scalable communications software that addresses the challenges of building and...